Compare APP & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APP | ISRG |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.6B | 176.2B |
| IPO Year | 2021 | 1998 |
| Metric | APP | ISRG |
|---|---|---|
| Price | $449.41 | $478.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | ★ $703.71 | $611.07 |
| AVG Volume (30 Days) | ★ 4.5M | 1.4M |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.23 | 22.59 |
| EPS | ★ 9.75 | 7.87 |
| Revenue | $5,480,717,000.00 | ★ $10,064,700,000.00 |
| Revenue This Year | $47.55 | $16.73 |
| Revenue Next Year | $29.08 | $13.86 |
| P/E Ratio | ★ $45.64 | $60.70 |
| Revenue Growth | 16.38 | ★ 20.51 |
| 52 Week Low | $200.50 | $425.27 |
| 52 Week High | $745.61 | $603.88 |
| Indicator | APP | ISRG |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 40.04 |
| Support Level | $368.10 | $463.61 |
| Resistance Level | $473.69 | $487.19 |
| Average True Range (ATR) | 23.70 | 12.51 |
| MACD | 2.85 | -0.41 |
| Stochastic Oscillator | 36.37 | 43.79 |
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.